Clinical Trial Update: Granisetron Transdermal Patch for Prophylaxis of Delayed CINV [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for granisetron transdermal patch intended to prevent delayed chemotherapy-induced nausea and vomiting (CINV).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Granisetron transdermal patch (granisetron)

Snippet

Sponsor: Fudan University | Conditions: Chemotherapy-induced Nausea and Vomiting (CINV) | Phase 3 | Status: UNKNOWN